glp-1 news november 2025 Harvard Medical School Researcher Wins Breakthrough Prize for Work on GLP-1 Weight Loss Drug Enforcement
Description
A review of the effects of glucagon-like Peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors on lean body mass in humans
10.1007/s00125-023-06072-6
But heres the good news: Youre not alone, and youre not expected to figure it out by yourself
Baisley and Baldo, 2014
Talk to your diabetes care team about whether a GLP-1 receptor agonist is appropriate for you approved options already exist
These treatments have fundamentally changed how we address chronic weight management by working with the bodys natural biology to manage appetite
